Related references
Note: Only part of the references are listed.Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma
YunMi Qiu et al.
ACTA DERMATO-VENEREOLOGICA (2022)
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
Husein Husein-ElAhmed et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Prurigo Nodularis
Shawn G. Kwatra
JAMA DERMATOLOGY (2022)
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease
Silvia Ferrucci et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Dupilumab: A Safe and Successful Treatment in Refractory Prurigo Nodularis
Ines Machado Cunha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report
Ilaria Sammarra et al.
BRAIN SCIENCES (2022)
Ustekinumab plus dupilumab in the treatment of concomitant psoriasis and prurigo nodularis
M. Kabbani et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Safety and Effectiveness of Dupilumab in Prurigo Nodularis
Ciro Romano
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2021)
Our experience with prurigo nodularis treated with dupilumab
G. Tilotta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Dupilumab for pediatric prurigo nodularis: A case report
Tahel Fachler et al.
PEDIATRIC DERMATOLOGY (2021)
Long-term Dupilumab Treatment for Chronic Refractory Generalized Prurigo Nodularis: A Retrospective Cohort Study
Jorge R. Georgakopoulos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy
Taoming Liu et al.
JOURNAL OF ASTHMA AND ALLERGY (2021)
Dupilumab in HIV-positive patients with atopic dermatitis: a long-term follow-up patient and a literature review
Gianluca Avallone et al.
Dermatology Online Journal (2021)
Dupilumab treatment of prurigo nodularis in an adolescent
Mattia Giovannini et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2021)
Diagnostic and treatment algorithm for chronic nodular prurigo
Hartmut F. Staender et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis
Maddalena Napolitano et al.
DERMATITIS (2020)
Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases
Amy H. Huang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis
A. N. Voorberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients
A. Calugareanu et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Dupilumab for prurigo nodularis: Case series and review of the literature
Jesper Gronlund Holm et al.
DERMATOLOGIC THERAPY (2020)
Efficacy of dupilumab in prurigo nodularis in elderly patient
Maria T. Giura et al.
DERMATOLOGIC THERAPY (2020)
Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?
G. Pistone et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Breaking the Itch-Scratch Cycle in Prurigo Nodularis
Shawn G. Kwatra
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dupilumab for treatment-refractory prurigo nodularis
Balint Kovacs et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2020)
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo
Andrea Chiricozzi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Pathogenesis and management
Kyle A. Williams et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis
Paulo R. Criado et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
Jill K. Wieser et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Dramatic improvement of generalized prurigo nodularis with dupilumab
A. Calugareanu et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion
J. P. Thyssen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
D. S. Bakker et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Dupilumab Treatment for Generalized Prurigo Nodularis
Kristen M. Beck et al.
JAMA DERMATOLOGY (2019)
Reduced Itch Associated With Dupilumab Treatment in 4 Patients With Prurigo Nodularis
Nicholas K. Mollanazar et al.
JAMA DERMATOLOGY (2019)
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo
M. P. Pereira et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Maurizio Mennini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Landon K. Oetjen et al.
CELL (2017)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis
S. Fukushi et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Share Paper
